Respiratory Medicine
Volume 101, Issue 5 , Pages 944-950 , May 2007

Cytokine gene polymorphisms and high-resolution-computed tomography score in idiopathic pulmonary fibrosis

  • Martina Vasakova

      Affiliations

    • Department of Respiratory Diseases, 1st Medical School, Charles University, University Thomayer Hospital, Videnska 800, 140 59 Prague 4, Czech Republic
    • Corresponding Author InformationCorresponding author. Tel.: +420261083728; fax: +420241951417.
    • ,
  • Ilja Striz

      Affiliations

    • Department of Immunology, Institute for Clinical and Experimental Medicine, Videnska 1958/9, 140 59, Prague, Czech Republic
    • ,
  • Juraj Dutka

      Affiliations

    • Radiologic Department, University Thomayer Hospital, Videnska 800, 140 59 Prague 4, Czech Republic
    • ,
  • Antonij Slavcev

      Affiliations

    • Department of Immunology, Institute for Clinical and Experimental Medicine, Videnska 1958/9, 140 59, Prague, Czech Republic
    • ,
  • Sarka Jandova

      Affiliations

    • Department of Anthropology, Charles University, Vinicna 8, 120 00 Prague 2, Czech Republic
    • ,
  • Libor Kolesar

      Affiliations

    • Department of Immunology, Institute for Clinical and Experimental Medicine, Videnska 1958/9, 140 59, Prague, Czech Republic
    • ,
  • Jan Sulc

      Affiliations

    • Cardiocenter, University Hospital Motol, V Úvalu 54, 150 06 Prague 5, Czech Republic

Received 10 April 2006 ,Accepted 10 September 2006.

References 

  1. Kelly M, Kolb M, Bonniaud P, Gauldie J. A re-evaluation of fibrogenic cytokines in lung fibrosis. Curr Pharm Des. 2003;9:39–49
  2. Lukacs NW, Hogaboam C, Chensue SW, Blease K, Kunkel SL. Type 1/type2 cytokine paradigm and the progression of pulmonary fibrosis. Chest. 2001;120:
  3. Cook DN, Brass DM, Schwarz DA. A matrix for new ideas in pulmonary fibrosis. Am J Respir Mol Biol. 2002;27:122–124
  4. Cooper JA. Pulmonary fibrosis: pathways are slowly coming into light. Am J Respir Cell Mol Biol. 2000;22:520–523
  5. Kuwano K, Hagimoto N, Hara N. Molecular mechanisms of pulmonary fibrosis and current treatment. Curr Mol Med. 2001;1:551–573
  6. du Bois RM. The genetic predisposition to interstitial lung diseases. Functional relevance. Chest. 2002;121(3):14–20
  7. Barth RK, Hanchett LA, Baecher-Allan CM. Mapping susceptibility genes for the induction of pulmonary fibrosis in mice. Chest. 2002;121(3):21
  8. Verleden GM, du Bois RM, Bouros D, Drent M, Millar A, Muller-Quernheim J, et al. Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin. Eur Respir J Suppl. 2001;32:17–29
  9. Brody AR, Warshamana GS, Liu JY, Liu JY, Tsai SY, Pociask DA, et al. Identifying fibrosis susceptibility genes in two strains of inbred mice. Chest. 2002;121:31
  10. Whittington HA, Freeburn RW, Godinho SIH, Egan J, Haider Y, Millar AB. Analysis of an IL-10 polymorphism in idiopathic pulmonary fibrosis. Gen Immun. 2003;258–264
  11. Lee CG, Homer RJ, Zhu Z, Lanone S, Wang X, Koteliansky V, et al. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta 1. J Exp Med. 2001;194:809–821
  12. Pantelidis P, Fanning GC, Wells AU, Welsh KI, Du Bois RM. Analysis of tumor necrosis factor- alpha, lymphotoxin-alpha, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2001;163(6):1432–1436
  13. Whyte M, Hubbard R, Meliconi R, Whidborne M, Eaton V, Bingle C, et al. Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism. Am J Respir Crit Care Med. 2000;162:755–758
  14. Xaubet A, Marin-Arguedas A, Lario S, Ancochea J, Morell F, Ruiz-Manzano J, et al. Transforming growth factor-beta 1gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003;168:431–435
  15. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnot PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation. 1998;66:1014–1020
  16. Freeburn RW, Kendall H, Dobson L, Egan J, Simler NJ, Millar AB. The 3′ untranslated region of tumor necrosis factor-alpha is highly conserved in idiopathic pulmonary fibrosis. Eur Cytokine Netw. 2001;12:33–38
  17. Hutyrova B, Pantelidis P, Drabek J, Zurkova M, Kolek V, Lenhart K, et al. Interleukin-1 gene cluster polymorphism in sarcoidosis and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2002;165:148–151
  18. Vasakova M, Striz I, Slavcev A, Jandova S, Kolesar L, Sulc J. Th1/Th2 cytokine gene polymorphisms in patients with idiopathic pulmonary fibrosis. Tissue Antigens. 2006;67:229–232
  19. Raghu G, Mageto YN, Lockhart D, Schmidt RA, Wood DE, Godwin JD. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease. Chest. 1999;116:1168–1174
  20. Peckham RM, Shorr AF, Helman DL. Potential limitation of clinical criteria for the diagnosis of idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitis. Respiration. 2004;71:165–169
  21. Diette GB, Scatarige JC, Haponik EF, Merriman B, Fishman EK. Do high-resolution CT findings of usual interstitial pneumonitis obviate lung biopsy? View of pulmonologists. Respiration. 2005;72:127–128
  22. Lynch DA, Godwin JD, Safrin S, Starko KM, Hormel P, Brown KK, et al. High-resolution computed tomography in idiopathic pulmonary fibrosis. Diagnosis and prognosis. Am J Respir Crit Care Med. 2005;172:488–493
  23. Mura M, Belmonte G, Fanti S, Contini P, Pacilli AM, Fasano L, et al. Inflammatory activity is still present in the advanced stages of idiopathic pulmonary fibrosis. Respirology. 2005;10:609–614
  24. Best AC, Lynch AM, Bozic CM, Miller D, Grunwald GK, Lynch DA. Quantitative CT indexes in idiopathic pulmonary fibrosis: relationship with physiologic impairment. Radiology. 2003;228:407–414
  25. Battista G, Zompatori M, Fasano L, Pacilli A, Basile B. Progressive worsening of idiopathic pulmonary fibrosis. High resolution computed tomography (HRCT) study with functional correlations. Radiol Med. 2003;105:2–11
  26. Fasano L, Zompatori M, Monetti N, Battista G, Pacilli AM, Scioscio VD, et al. Idiopathic interstitial pneumonitis presenting with Wells grade III. Can imaging methods predict further progression of disease?. Radiol Med. 1999;98:268–274
  27. Wells A, Hansell D, Rubens M, Cullinan P, Black C, duBois R. The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis. Am Rev Respir Dis. 1993;148:1076–1082
  28. Kazerooni E, Martinez F, Flint A, Jamadar D, Gross B, Spiyarny D, et al. Thin-section CT obtained at 10mm increments versus three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. Am J Roentgenol. 1997;169:977–983
  29. Gay SE, Kazerooni EA, Tows GB, Lynch JP, Gross BH, Cascade PN, et al. Idiopathic pulmonary fibrosis. Predicting response to therapy and survival. Am J Respir Crit Care Med. 1998;157:1063–1072
  30. Nagao T, Nagai S, Hiramoto Y, Hamada K, Shigematsu M, Hayashi M, et al. Serial evaluation of high-resolution computed tomography findings in patients with idiopathic pulmonary fibrosis in usual interstitial pneumonia. Respiration. 2002;69:413–419
  31. Hansell DM. High-resolution computed tomography in the evaluation of fibrosing alveolitis. Clin Chest Med. 1999;20:739–760
  32. Souza CA, Muller NL, Flint J, Wright JL, Churg A. Idiopathic pulmonary fibrosis: spectrum of high-resolution CT findings. Am J Roentgenol. 2005;185:1531–1539
  33. Schettino IA, Ab`Saber AM, Vollmer R, Saldiva PH, Carvalho CR, Kairalla RA, et al. Accuracy of high resolution CT in assesing idiopathic pulmonary fibrosis histology by objective morphometric index. Pathol Res Pract. 2002;198:347–354
  34. International Consensus statement: Idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2000;161:646–664
  35. Jakubzick C, Kunkel SL, Puri RK, Hogaboam CM. Therapeutic Targeting of 1L-4- and IL-13-responsive cells in pulmonary fibrosis. Immun Res. 2004;30/3:339–349
  36. Hall MA, McGlinn E, Coakley G, Fisher SA, Boki K, Middleton D, et al. Genetic polymorphism of IL-12 p40 gene in immune-mediated disease. Genes Immun. 2000;1:219–224
  37. Latsi P, Pantelidis P, Vassilakis D, Sato H, Welsh KI, du Bois RM. Analysis of IL-12 p40 subunit gene and IFN-gamma G5644A polymorphisms in idiopathic pulmonary fibrosis. Respir Res. 2003;4:6
  38. Selman M, Ruiz V, Cabrera S, Segura L, Ramírez R, Barrios R, et al. TIMP-1,-2,-3 and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment?. Am J Physiol Lung Cell Mol Physiol. 2000;279:562–574

PII: S0954-6111(06)00453-7

doi: 10.1016/j.rmed.2006.09.013

Respiratory Medicine
Volume 101, Issue 5 , Pages 944-950 , May 2007

Article Tools